Delivery Order SPE2DB22D2218-SPE2DB24FR2AE
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order for the supply of Diovan HCT 320-25 mg tablets, a brand name pharmaceutical product. The award has a ceiling value of $1,734.22 and a period of performance through April 5, 2024. Amerisourcebergen Drug Corp holds an...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,703.42 contract is for the delivery of Diovan HCT 320-12.5 mg tablets. The contract has an ultimate completion date of September 6, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The company holds a significant $999,999,999 Indefinite...
- This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of 4,561,608,706 units of Diovan HCT 160-25 mg tablets. The $1,532.38 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) and has a completion date of July 27, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of Diovan HCT 320-12.5 mg tablets, a cardiovascular medication, to the Defense Logistics Agency (DLA). The $3,170.36 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on April 8, 2022. The contract has an ultimate completion date of April 11, 2022 and does not include any set-aside requirements. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $38,200.86, is a delivery order for the supply of Diovan HCT 160-12.5 mg tablets. The contract has an ultimate completion date of December 16, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Diovan HCT 320-12.5 mg tablets. The contract is a Delivery Order valued at $11,255.98 with a Firm Fixed Price pricing type. The contract has an ultimate completion date of October 23, 2023 and was awarded on October 20, 2022. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Diovan HCT 320-12.5 mg tablets over a period ending on May 15, 2024, with a ceiling value of $8,816.05. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,199.52, is for the delivery of Diovan HCT 160-25 mg tablets. It is a firm-fixed-price delivery order contract with a completion date of June 25, 2024. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp's Corporate Office division is the prime contractor for this award, which is part...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation. The $5,333.84 firm fixed price delivery order is for the supply of Diovan HCT 160-25 mg tablets. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide pharmaceutical...
- This federal contract award, valued at $11,643.43, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Diovan HCT 320-12.5 mg tablets in quantities of 90 per bottle. This is a firm-fixed-price delivery order contract with a completion date of February 16, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
- SPE2DB22D2218Indefinite Delivery Contract
- SPE2DB22D2218-SPE2DB24FR2AEDelivery Order
This federal contract award, made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, is for the delivery of Diovan HCT 320-25 mg tablets. The award, valued at $29,382.03, is a firm fixed-price delivery order with a completion date of February 8, 2024. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor and healthcare solutions provider. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.4k | 2/7/24 |